echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Diabetes Obes Metab: Compared with insulin degludec alone, IDegLira can significantly reduce HbA1c, reduce weight and reduce the risk of hypoglycemia

    Diabetes Obes Metab: Compared with insulin degludec alone, IDegLira can significantly reduce HbA1c, reduce weight and reduce the risk of hypoglycemia

    • Last Update: 2021-08-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com



    Dthe I ( about 1,600 people ), the project is a 26-week, randomized, open the test, in T2D M announced Novo Nordisk after IDegLira of three research clinical research (Dual II) data, the study show, compared with Germany Valley insulin, compared with Germany Valley insulin, compared with Germany Valley insulin, IDegLira showed good efficacy and safety







    Table 1 Comparison of main observation indexes between IDegLira group and insulin deglu

    Table 2 Comparison of the proportion of glycated hemoglobin <7.


    Table 2 Comparison of the proportion of glycated hemoglobin <7.


    Therefore, IDegLira may be an effective and well-tolerated intensive treatment plan for Chinese T2DM patients whose basal insulin and oral hypoglycemic drugs are not effective


    Pei Y, Agner BR, Luo B, et al.




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.